- Home
- CASI vs BEDU Comparison
CASI vs BEDU Comparison
Compare CASI & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- BEDU
- Stock Information
- Founded
- CASI 1991
- BEDU 1994
- Country
- CASI China
- BEDU United Kingdom
- Employees
- CASI N/A
- BEDU N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- BEDU Other Consumer Services
- Sector
- CASI Health Care
- BEDU Real Estate
- Exchange
- CASI Nasdaq
- BEDU Nasdaq
- Market Cap
- CASI 58.8M
- BEDU 58.7M
- IPO Year
- CASI 1996
- BEDU 2017
- Fundamental
- Price
- CASI $3.09
- BEDU $1.67
- Analyst Decision
- CASI Strong Buy
- BEDU
- Analyst Count
- CASI 1
- BEDU 0
- Target Price
- CASI $6.00
- BEDU N/A
- AVG Volume (30 Days)
- CASI 56.2K
- BEDU 18.7K
- Earning Date
- CASI 11-15-2024
- BEDU 02-03-2025
- Dividend Yield
- CASI N/A
- BEDU N/A
- EPS Growth
- CASI N/A
- BEDU N/A
- EPS
- CASI N/A
- BEDU N/A
- Revenue
- CASI $22,055,000.00
- BEDU $247,588,726.00
- Revenue This Year
- CASI N/A
- BEDU N/A
- Revenue Next Year
- CASI $134.79
- BEDU N/A
- P/E Ratio
- CASI N/A
- BEDU N/A
- Revenue Growth
- CASI N/A
- BEDU N/A
- 52 Week Low
- CASI $2.05
- BEDU $1.24
- 52 Week High
- CASI $8.19
- BEDU $3.23
- Technical
- Relative Strength Index (RSI)
- CASI 39.70
- BEDU 42.66
- Support Level
- CASI $2.50
- BEDU $1.35
- Resistance Level
- CASI $3.47
- BEDU $1.79
- Average True Range (ATR)
- CASI 0.43
- BEDU 0.21
- MACD
- CASI 0.07
- BEDU -0.03
- Stochastic Oscillator
- CASI 39.80
- BEDU 39.51
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. The company offers overseas schools, complementary education services, and domestic kindergartens and K12 operation services. The group's overseas K12 education has several K12 schools, art colleges, language training institutions, and summer schools around the world. The complimentary education services segment of the company predominantly includes camp programs, after-school programs, through a network of learning centers in China, as well as international education consulting services. Geographically, the company operates in China which is the key revenue generating market, Canada, United States, and United Kingdom.